Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells

Biochemical Pharmacology

Volumn 55, Issue 10, 1998, Pages 1721-1727

  Walgren, Richard A ^a   Walle, U Kristina ^a   Walle, Thomas ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apparent permeability; Bioflavonoids; Caco 2 cells; Glucosides; Intestinal absorption; Quercetin

Indexed keywords

MANNITOL; PROPRANOLOL; QUERCETIN; QUERCETIN 3,4 DIGLUCOSIDE; QUERCETIN 4 GLUCOSIDE; UNCLASSIFIED DRUG;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CHEMICAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; TRANSCYTOSIS;

CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; GLUCOSIDES; HUMANS; INTESTINAL MUCOSA; QUERCETIN;

EID: 0032524982     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00048-3     Document Type: Article

References (39)

1. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vege tables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem. 40:1992;2379-2383.
2. Hertog MGL, Hollman PCH, van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem. 41:1993;1242-1246.
3. Kiviranta J, Huovinen K, Hiltunen R. Variation of phenolic substances in onion. Acta Pharm Fenn. 97:1988;67-72.
4. Knekt P, Järvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland A cohort study . Br Med J. 312:1996;478-481.
5. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke The Zutphen study . Arch Intern Med. 156:1996;637-642.
6. Cook NC, Samman S. Flavonoids - Chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 7:1996;66-76.
7. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis Implications for protection against coronary heart disease . Clin Chim Acta. 235:1995;207-219.
8. Ji X, Melman N, Jacobson KA. Interactions of flavonoids and other phytochemicals with adenosine receptors. J Med Chem. 39:1996;781-788.
9. Deschner EE, Ruperto J, Wong G, Newark HL. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis. 12:1991;1193-1196.
10. Deschner EE, Ruperto JF, Wong GY, Newmark HL. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer. 20:1993;199-204.
11. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA. 92:1995;5258-5265.
12. Wang ZY, Huang M-T, Lou Y-R, Xie J-G, Reuhl KR, Newmark HL, Ho C-T, Yang CS, Conney AH. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res. 54:1994;3428-3435.
13. Weber G, Shen F, Prajda N, Yeh YA, Yang H, Herenyiova M, Look KY. Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Res. 16:1996;3271-3282.
14. 1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog. 19:1997;74-82.
15. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wähälä K, Montesano R, Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 57:1997;2916-2921.
16. Tsyrlov IB, Mikhailenko VM, Gelboin HV. Isoenzyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochim Biophys Acta. 1205:1994;325-335.
17. Walle T, Eaton EA, Walle UK. Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochem Pharmacol. 50:1995;731-734.
18. Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol. 9:1975;229-234.
19. 14C]quercetin in the ACI rat. Jpn J Exp Med. 53:1983;41-50.
20. Manach C, Morand C, Texier O, Favier M-L, Agullo G, Demigné C, Régérat F, Rémésy C. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr. 125:1995;1911-1922.
21. Bokkenheuser VD, Shackleton CHL, Winter J. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J. 248:1987;953-956.
22. Hollman PCH, de Vries JHM, van Leeuwen SD, Mengelers MJB, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr. 62:1995;1276-1282.
23. Artursson P. Epithelial transport of drugs in cell culture. I A model for studying the passive diffusion of drugs over intestinal absorbtive (Caco-2) cells . J Pharm Sci. 79:1990;476-482.
24. Hunter J, Hirst BH, Simmons NL. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm Res. 10:1993;743-749.
25. Meunier V, Bourrié M, Berger Y, Fabre G. The human intestinal epithelial cell line Caco-2; Pharmacological and pharmacokinetic applications. Cell Biol Toxicol. 11:1995;187-194.
26. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 175:1991;880-885.
27. Lennernäs H. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J Pharm Pharmacol. 49:1997;627-638.
28. Price KR, Rhodes MJC. Analysis of the major flavonol glycosides present in four varieties of onion (Allium cepa) and changes in composition resulting from autolysis. J Sci Food Agric. 74:1997;331-339.
29. Cogbum JN, Donovan MG, Schasteen CS. A model of human small intestinal absorptive cells. 1. Transport barrier. Pharm Res. 8:1991;210-216.
30. Lu S, Gough AW, Bobrowski WF, Stewart BH. Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes. J Pharm Sci. 85:1996;270-273.
31. Hertog MGL, Feskens EJM, Holiman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease The Zutphen Elderly Study . Lancet. 342:1993;1007-1011.
32. Shapiro AB, Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol. 53:1997;587-596.
33. Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem. 268:1993;14991-14997.
34. Stein WD. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev. 77:1997;545-590.
35. Lautier D, Canitrot Y, Deeley RG, Cole SPC. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol. 52:1996;967-977.
36. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama S, Kuwano M. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56:1996;4124-4129.
37. Mahraoui L, Rodolosse A, Barbat A, Dussaulx E, Zweibaum A, Rousset M, Brot-Laroche E. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem J. 298:1994;629-633.
38. Mesonero J, Matosin M, Cambier D, Rodriguez-Yoldi M-J, Brot-Laroche E. Sugar-dependent expression of the fructose transporter GLUT5 in Caco-2 cells. Biochem J. 312:1995;757-762.
39. Noteborn HPJM, Jansen E, Benito S, Mengelers MJB. Oral absorption and metabolism of quercetin and sugar-conjugated derivatives in specific transport systems. Cancer Lett. 114:1997;175-177.